Jan Karlseder

Jan Karlseder

Auto-generated profile, based on publicly available information

Jan Karlseder


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2010 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
RORoderick J. O'SUllivan
Roderick J. O'SUllivan
JKJan Karlseder
Jan Karlseder

3 October 2010 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
RORoderick J O'Sullivan
Roderick J O'Sullivan
SKStefan Kubicek
Stefan Kubicek
SSStuart L Schreiber
Stuart L Schreiber
JKJan Karlseder
Jan Karlseder
Telomere shortening, senescence and aging are connected, but how the signal at shortening telomeres is transmitted to the cell more globally is unclear. H3 and H4 synthesis is now shown to be reduced as cell cultures age. This alters expression of Asf1, a histone chaperone, compromising the ability of aging cells to restore chromatin after replication and DNA. In this way localized effects at shortening telomeres can be propagated throughout the cell. During replicative aging of primary cells morphological transformations occur, the expression pattern is altered and chromatin changes globally. Here we show that chronic damage signals, probably caused by telomere processing, affect expression of histones and lead to their depletion. We investigated the abundance and cell cycle expression of histones and histone chaperones and found defects in histone biosynthesis during replicative aging. Simultaneously, epigenetic marks were redistributed across the phases of the cell cycle and the DNA damage response (DDR) machinery was activated. The age-dependent reprogramming affected telomeric chromatin itself, which was progressively destabilized, leading to a boost of the telomere-associated DDR with each successive cell cycle. We propose a mechanism in which changes in the structural and epigenetic integrity of telomeres affect core histones and their chaperones, enforcing a self-perpetuating pathway of global epigenetic changes that ultimately leads to senescence.

23 January 2019 in Nature
Verified
Journal Article
Closed access
PDF file
JNJoe Nassour
Joe Nassour
RRRobert Radford
Robert Radford
ACAdriana Correia
Adriana Correia
JFJavier Miralles Fusté
Javier Miralles Fusté
BSBrigitte Schoell
Brigitte Schoell
JKJan Karlseder
Jan Karlseder

28 September 2017 in Nature
Verified
Journal Article
Open access
PDF file
NANausica Arnoult
Nausica Arnoult
ACAdriana Correia
Adriana Correia
JMJiao Ma
Jiao Ma
AMAnna Merlo
Anna Merlo
SGSara Garcia-Gomez
Sara Garcia-Gomez
JKJan Karlseder
Jan Karlseder
CYREN is a direct inhibitor of classical non-homologous end joining that promotes error-free repair by homologous recombination during the S and G2 phases of the cell cycle. A broken DNA molecule can be repaired in two distinct ways: homologous recombination, or classical non-homologous end joining (cNHEJ). Both processes function in the S and G2 phases of the cell cycle, but why cNHEJ is not always used is unknown. Jan Karlseder and colleagues have found that cNHEJ is suppressed in S and G2 by CYREN (cell cycle regulator of NHEJ), which binds to the Ku complex to inhibit the initial steps of end joining. The absence of CYREN results in genomic instability. CYREN thus biases repair in S and G2, when sister chromatids are available, to a recombination process that, unlike cNHEJ, is error-free. Classical non-homologous end joining1 (cNHEJ) and homologous recombination2 compete for the repair of double-stranded DNA breaks during the cell cycle. Homologous recombination is inhibited during the G1 phase of the cell cycle, but both pathways are active in the S and G2 phases. However, it is unclear why cNHEJ does not always outcompete homologous recombination during the S and G2 phases. Here we show that CYREN (cell cycle regulator of NHEJ) is a cell-cycle-specific inhibitor of cNHEJ. Suppression of CYREN allows cNHEJ to occur at telomeres and intrachromosomal breaks during the S and G2 phases, and cells lacking CYREN accumulate chromosomal aberrations upon damage induction, specifically outside the G1 phase. CYREN acts by binding to the Ku70/80 heterodimer and preferentially inhibits cNHEJ at breaks with overhangs by protecting them. We therefore propose that CYREN is a direct cell-cycle-dependent inhibitor of cNHEJ that promotes error-free repair by homologous recombination during cell cycle phases when sister chromatids are present.

12 January 2014 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
RORoderick J O'SUllivan
Roderick J O'SUllivan
NANausica Arnoult
Nausica Arnoult
DLDaniel H Lackner
Daniel H Lackner
LOLiana Oganesian
Liana Oganesian
CHCandy Haggblom
Candy Haggblom
JKJan Karlseder
Jan Karlseder
Some cancer cells lacking telomerase activity extend their telomeres via an alternative, recombination-based mechanism, termed ALT. A new study shows that depletion of histone chaperone ASF1 can induce ALT in both primary and cancer cells, suggesting that the ALT pathway may be triggered by changes in chromatin state. The mechanism of activation of the alternative lengthening of telomeres (ALT) pathway of mammalian chromosome-end maintenance has been unclear. We have now discovered that co-depletion of the histone chaperones ASF1a and ASF1b in human cells induced all hallmarks of ALT in both primary and cancer cells. These included the formation of ALT-associated PML (promyelocytic leukemia) bodies (APBs), the presence of extrachromosomal telomeric DNA species, an elevated frequency of telomeric sister chromatid exchanges (t-SCE) events and intertelomeric exchange of an integrated tag. The induction of ALT characteristics in this setting led to the simultaneous suppression of telomerase. We determined that ALT induction is positively regulated by the proteins RAD17 and BLM and negatively regulated by EXO1 and DNA2. The induction of ALT phenotypes as a consequence of ASF1 depletion strongly supports the hypothesis that ALT is a consequence of histone management dysfunction.

13 February 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LCLaure Crabbe
Laure Crabbe
AJAnna Jauch
Anna Jauch
CNColleen M. Naeger
Colleen M. Naeger
HHHeidi Holtgreve-Grez
Heidi Holtgreve-Grez
JKJan Karlseder
Jan Karlseder
Werner syndrome (WS) is a rare human premature aging disease caused by mutations in the gene encoding the RecQ helicase WRN. In addition to the aging features, this disorder is marked by genomic instability, associated with an elevated incidence of cancer. Several lines of evidence suggest that telomere dysfunction is associated with the aging phenotype of the syndrome; however, the origin of the genomic instability observed in WS cells and the reason for the high incidence of cancer in WS have not been established. We previously proposed that WRN helicase activity was necessary to prevent dramatic telomere loss during DNA replication. Here we demonstrate that replication-associated telomere loss is responsible for the chromosome fusions found in WS fibroblasts. Moreover, using metaphase analysis we show that telomere elongation by telomerase can significantly reduce the appearance of new chromosomal aberrations in cells lacking WRN, similar to complementation of WS cells with WRN. Our results suggest that the genome instability in WS cells depends directly on telomere dysfunction, linking chromosome end maintenance to chromosomal aberrations in this disease.